{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:39:23Z","timestamp":1792528763026,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]},{"name":"U.S. Agency for International Development","award":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"],"award-info":[{"award-number":["Cooperative Agreement(s) 7200AA20CA00002 and 7200AA20CA00007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postpartum hemorrhage (PPH) and Hypertensive Disorders of Pregnancy (HDP) remain leading causes of maternal death. This multi-country survey asked key informants to assess uptake of evidence-based practices; determine their country\u2019s implementation of updated WHO global guidelines; and describe the private sector\u2019s role in PPH and HDP management. To our knowledge, this is among the few multi-country assessments to examine national implementation of updated WHO recommendations for PPH and HDP alongside private-sector engagement across three major regions\u2014sub-Saharan Africa, South and Southeast Asia, and Latin America and the Caribbean\u2014providing a comparative view to guide advocacy and programme planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From January to May 2022, 35 countries in sub-Saharan Africa, South and Southeast Asia, and Latin America and the Caribbean were invited to complete a survey (based on 2011 and 2012 surveys) on PPH and HDP management across public and private sectors on PPH and HDP management. Using purposive sampling, country-based focal persons assembled national expert teams from public and private sectors in health policy, education, procurement\/distribution, logistics, and information systems to complete the survey. Teams produced consensus-based answers by reviewing nationally available data and policy documents. The Study Team developed composite scores for key quantitative indicators and thematically analyzed qualitative data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-one countries completed the survey. Despite significant progress since 2012, several gaps remain. Oxytocin was reported as regularly available in public facilities by 77% of countries and in private facilities by 84% of countries. Magnesium sulfate was reported as available in public facilities by 58% of countries and in private facilities by 45% of countries. Interventions like umbilical vein injection of oxytocin for retained placenta (13% of countries) and heat-stable carbetocin for PPH prevention (45% of countries) were less integrated in national policy guidelines. Since 2011, midwifery scope of practice remained stagnant for manual removal of placenta for PPH, diagnosing severe pre-eclampsia\/eclampsia, and giving the loading dose of MgSO4, but 60% of countries in 2022 reported that newer PPH treatments (such as tranexamic acid) were included. Quality assurance systems for procurement of essential drugs and data reporting into national information systems were deficient, particularly in the private sector. Conclusions: Recommendations include prioritizing integration of updated global guidelines; improving uptake through professional education, mentorship, and supervision; quality assurance; strengthening procurement and supply chains to improve access, availability, and quality of essential drugs and commodities; expanding midwives\u2019 scope of practice; and improving private sector governance to enhance reporting of important MNH indicators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09679-w","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:55:16Z","timestamp":1784555716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention and management of postpartum hemorrhage and hypertensive disorders of pregnancy: results from a 31-country rapid assessment"],"prefix":"10.1186","volume":"26","author":[{"given":"Gaurav","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeline","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleefia","family":"Somji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Blockett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blami","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Virginia Camacho","family":"Hubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Stalls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"6","key":"9679_CR1","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tun\u00e7alp \u00d6, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u2013333.","journal-title":"Lancet Glob Health"},{"key":"9679_CR2","unstructured":"Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group., and UNDESA\/Population Division. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240068759.\u00a0Cited 12 Feb 2024."},{"key":"9679_CR3","unstructured":"Organization WH. A roadmap to combat postpartum haemorrhage between 2023 and 2030. In: a roadmap to combat postpartum haemorrhage between 2023 and 2030. 2023. Available from: https:\/\/iris.who.int\/handle\/10665\/373221. Cited 16 Feb 2024."},{"key":"9679_CR4","unstructured":"WHO recommendations. drug treatment for severe hypertension in pregnancy. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241550437. Cited 12 Feb 2024."},{"issue":"4","key":"9679_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.9745\/GHSP-D-15-00350","volume":"3","author":"S Hodgins","year":"2015","unstructured":"Hodgins S. Pre-eclampsia as Underlying Cause for Perinatal Deaths: Time for Action. Glob Health Sci Pract. 2015;3(4):525\u20137.","journal-title":"Glob Health Sci Pract"},{"issue":"3","key":"9679_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.9745\/GHSP-D-14-00034","volume":"2","author":"JM Smith","year":"2014","unstructured":"Smith JM, Currie S, Cannon T, Armbruster D, Perri J. Are national policies and programs for prevention and management of postpartum hemorrhage and preeclampsia adequate? A key informant survey in 37 countries. Glob Health Sci Pract. 2014;2(3):275\u201384.","journal-title":"Glob Health Sci Pract"},{"key":"9679_CR7","unstructured":"Fujioka A. Prevention and management of postpartum hemorrhage and pre-eclampsia\/eclampsia: national programs in selected USAID program-supported countries: Maternal and Child Health Integrated Program (MCHIP) global status reports. 2011. Available from: https:\/\/www.mchip.net\/sites\/default\/files\/2011%20Progress%20Report_Full%20Report.pdf."},{"key":"9679_CR8","unstructured":"WHO recommendations:. uterotonics for the prevention of postpartum haemorrhage. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241550420. Cited 12 Feb 2024."},{"key":"9679_CR9","unstructured":"WHO recommendation on routes of oxytocin administration. for the prevention of postpartum haemorrhage after vaginal birth. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240013926. Cited 12 Feb 2024."},{"issue":"1","key":"9679_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2303966","volume":"389","author":"I Gallos","year":"2023","unstructured":"Gallos I, Devall A, Martin J, Middleton L, Beeson L, Galadanci H, et al. Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage. N Engl J Med. 2023;389(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"9679_CR11","unstructured":"WHO recommendation on uterine balloon. tamponade for the treatment of postpartum haemorrhage. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240013841. Cited 12 Feb 2024."},{"key":"9679_CR12","unstructured":"WHO recommendation on calcium supplementation before pregnancy for the prevention. of pre-eclampsia and its complications. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240003118. Cited 12 Feb 2024."},{"key":"9679_CR13","unstructured":"WHO recommendations. policy of interventionist versus expectant management of severe pre-eclampsia before term. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241550444. Cited 12 Feb 2024."},{"key":"9679_CR14","unstructured":"WHO recommendations on antiplatelet agents. for the prevention of pre-eclampsia. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240037540. Cited 12 Feb 2024."},{"key":"9679_CR15","unstructured":"WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta. 2024. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240013940. Cited 12 Feb 2024."},{"key":"9679_CR16","unstructured":"WHO recommendations on drug treatment for non-severe hypertension in pregnancy. 2024. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240008793. Cited 12 Feb 2024."},{"issue":"7","key":"9679_CR17","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1377\/hlthaff.2015.0862","volume":"35","author":"KA Gr\u00e9pin","year":"2016","unstructured":"Gr\u00e9pin KA. Private Sector An Important But Not Dominant Provider Of Key Health Services In Low- And Middle-Income Countries. Health Aff. 2016;35(7):1214\u201321.","journal-title":"Health Aff"},{"issue":"6","key":"9679_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2471\/BLT.16.179291","volume":"95","author":"G Sharma","year":"2017","unstructured":"Sharma G, Powell-Jackson T, Haldar K, Bradley J, Filippi V. Quality of routine essential care during childbirth: clinical observations of uncomplicated births in Uttar Pradesh, India. Bull World Health Organ. 2017;95(6):419\u201329.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"9679_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol. 2009;33(3):130\u20137.","journal-title":"Semin Perinatol"},{"issue":"Suppl 5","key":"9679_CR20","doi-asserted-by":"publisher","first-page":"e008939","DOI":"10.1136\/bmjgh-2022-008939","volume":"8","author":"SR Lattof","year":"2023","unstructured":"Lattof SR, Maliqi B, Yaqub N, Asiedu EK, Ukaire B, Ojo O, et al. Engaging the private sector to deliver quality maternal and newborn health services for universal health coverage: lessons from policy dialogues. BMJ Glob Health. 2023;8(Suppl 5):e008939.","journal-title":"BMJ Glob Health"},{"key":"9679_CR21","unstructured":"International Confederation of Midwives. Essential competencies for midwifery practice. Available from: https:\/\/internationalmidwives.org\/resources\/essential-competencies-for-midwifery-practice\/. Cited 12 Feb 2024."},{"key":"9679_CR22","volume-title":"A global review of the key interventions related to reproductive, maternal, newborn and child health (RMNCH)","author":"Partnership for Maternal N& CH","year":"2011","unstructured":"Partnership for Maternal N& CH. A global review of the key interventions related to reproductive, maternal, newborn and child health (RMNCH). Switzerland: PMNCH Geneva; 2011."},{"issue":"1","key":"9679_CR23","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/S2214-109X(20)30397-1","volume":"9","author":"A Nove","year":"2021","unstructured":"Nove A, Friberg IK, de Bernis L, McConville F, Moran AC, Najjemba M, et al. Potential impact of midwives in preventing and reducing maternal and neonatal mortality and stillbirths: a Lives Saved Tool modelling study. Lancet Global Health. 2021;9(1):e24\u201332.","journal-title":"Lancet Global Health"},{"issue":"4","key":"9679_CR24","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S2214-109X(16)00046-2","volume":"4","author":"PM Pronyk","year":"2016","unstructured":"Pronyk PM, Nemser B, Maliqi B, Springstubb N, Sera D, Karimov R, et al. The UN Commission on Life Saving Commodities 3 years on: global progress update and results of a multicountry assessment. Lancet Global Health. 2016;4(4):e276\u201386.","journal-title":"Lancet Global Health"},{"key":"9679_CR25","unstructured":"Ending preventable maternal mortality (EPMM). a renewed focus for improving maternal and newborn health and well-being. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240040519. Cited 12 Feb 2024."},{"key":"9679_CR26","unstructured":"Ending preventable newborn deaths and stillbirths by 2030 | UNICE. 2020. Available from: https:\/\/www.unicef.org\/reports\/ending-preventable-newborn-deaths-stillbirths-quality-health-coverage-2020-2025. Cited 16 Feb 2024."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09679-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09679-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09679-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:01:52Z","timestamp":1792526512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09679-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9679"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09679-w","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This survey obtained a Non-Human Subjects Research determination from the Institutional Review Board Office of the John Hopkins Bloomberg School of Public Health (IRB No. 19844) on February 11, 2022.Informed written consent was voluntarily obtained from all key informants in English, French, Spanish, or Portuguese, as appropriate. Participants were assured of both anonymity and confidentiality. They received an information sheet with a detailed description of the study and were informed of their right to decline participation or withdraw consent at any point during the interview.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1191"}}